Sawai Group Holdings Co., Ltd. (TYO:4887)
1,921.00
-8.00 (-0.41%)
Aug 22, 2025, 3:30 PM JST
Sawai Group Holdings Revenue
Sawai Group Holdings had revenue of 49.51B JPY in the quarter ending June 30, 2025, with 11.69% growth. This brings the company's revenue in the last twelve months to 194.21B, up 15.46% year-over-year. In the fiscal year ending March 31, 2025, Sawai Group Holdings had annual revenue of 189.02B with 6.88% growth.
Revenue (ttm)
194.21B
Revenue Growth
+15.46%
P/S Ratio
1.14
Revenue / Employee
58.67M
Employees
3,310
Market Cap
221.78B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 189.02B | 12.16B | 6.88% |
Mar 31, 2024 | 176.86B | -23.48B | -11.72% |
Mar 31, 2023 | 200.34B | 6.53B | 3.37% |
Mar 31, 2022 | 193.82B | 6.60B | 3.52% |
Mar 31, 2021 | 187.22B | 4.68B | 2.56% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
Takeda Pharmaceutical Company | 4,480.25B |
Daiichi Sankyo Company | 1,924.68B |
HOYA Corporation | 876.09B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |